Tech Company Financing Transactions
Magnolia Neurosciences Funding Round
Magnolia Neurosciences secured a $31 million Series A funding round on 8/14/2018. Investors included 180 Degree Capital, AbbVie Biotech Ventures and Alexandria Venture Investments.
Transaction Overview
Company Name
Announced On
8/14/2018
Transaction Type
Venture Equity
Amount
$31,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
430 E 29th St. 840
New York, NY 10016
USA
New York, NY 10016
USA
Phone
Email Address
Overview
Neurodegenerative diseases and neuronal injuries continue to be an area rife with substantial unmet medical need. Targeting the underlying mechanisms of these diseases is an area of active research for effective therapeutic interventions, but extensive preclinical and clinical efforts have unfortunately resulted in limited success.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thong Le
Browse more venture capital transactions:
Prev: 8/14/2018: SKUPOS venture capital transaction
Next: 8/15/2018: Axoni venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs